Characteristics of DNMT3a mutation in acute myeloid leukemia and its prognostic implication
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Characteristics of DNMT3a mutation in acute myeloid leukemia and its prognostic implication ; volume:25 ; number:1 ; day:2 ; month:9 ; year:2024 ; pages:1-13 ; date:12.2024
The Egyptian journal of medical human genetics ; 25, Heft 1 (2.9.2024), 1-13, 12.2024
- Urheber
-
Khattab, Ahmed Mahmoud Taha
Ghaffar, Afaf Abdel Aziz Abdel
El-Sewefy, Dalia Ahmed
ElSakhawy, Yasmin Nabil
Salem, Ramy Mahmoud
Omar, Heba Samy Agamy
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43042-024-00570-x
- URN
-
urn:nbn:de:101:1-2411180021427.271139268941
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Khattab, Ahmed Mahmoud Taha
- Ghaffar, Afaf Abdel Aziz Abdel
- El-Sewefy, Dalia Ahmed
- ElSakhawy, Yasmin Nabil
- Salem, Ramy Mahmoud
- Omar, Heba Samy Agamy
- SpringerLink (Online service)
Ähnliche Objekte (12)
Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia
DNMT3A mutations in chronic myeloid leukemia
DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway
DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming
Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia
The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation
DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia
Landscape of biallelic DNMT3A mutant myeloid neoplasms
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia
Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia
DNMT3A mutations in chronic myeloid leukemia
DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway
DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming
Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia
The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation
DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia
Landscape of biallelic DNMT3A mutant myeloid neoplasms
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia
Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia
DNMT3A mutations in chronic myeloid leukemia
DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway
DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming
Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia
The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation
DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia
Landscape of biallelic DNMT3A mutant myeloid neoplasms
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia